Hello!
Kishor Wasan
has received numerous awards for his contributions to health sciences
About Me
Dr. Wasan has received numerous awards for his contributions to health sciences including the Canadian Society of Pharmaceutical Sciences Leadership award for outstanding contributions to Pharmaceutical Sciences in Canada and is a Fellow of the Canadian Academy of Health Sciences and the American Association of Pharmaceutical Scientists. Dr. Wasan has published over 240 peer-reviewed articles and 280 abstracts in the area of lipid-based drug delivery and lipoprotein-drug interactions. Most recently, Dr. Wasan served as the Dean of the College of Pharmacy and Nutrition of the University of Saskatchewan from August 2014 to June 2019. Dr. Wasan led the research team at the Wasan lab at the University of British Columbia that developed what has become iCo 019, and will initially focus his efforts on the further development of iCo 019 via partnerships and collaborations.
Click "Learn More" to see the full bio on Professor Kishor Wasan
Learn MorePortfolio
Kishor Wasan Portfolio
Recent News
June 5, 2023
Role of the Lymphatic System in Drug Absorption
Honored to be selected by the prestigious Henry Stewart Talks (HSTalks https://hstalks.com/) to provide a lecture on the role of the lymphatic system on improving the absorption and bioavailability of drugs. Thank you Dr. Vladimir Torchilin for the generous invitation to participate. Talk Citation: Wasan, K.M. (2023, May 31). Role of the lymphatic system in […]
May 8, 2023
NGDI UBC are leading a Special Issue in Frontiers in Pharmacology
NGDI UBC are leading a Special Research Topic in Frontiers in Pharmacology on Novel Pharmacological Targets and Strategies to treat Neglected Tropical Diseases- An LMIC Perspective Due Date December 8th, 2023; Details are in the link below: https://www.frontiersin.org/research-topics/55670/novel-pharmacological-targets-and-strategies-to-treat-neglected-global-diseases-ngds-an-lmic-perspective
April 22, 2023
New CIHR Grant for Drs. Cox and Wasan to investigate strategies to treat Advanced Prostate Cancer
New CIHR Funding for NDGI Co-Director: https://www.med.ubc.ca/news/faculty-of-medicine-researchers-awarded-26-million-through-cihr-project-grants/ Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469855&lang=en UBC Principal Investigator(s): Michael Cox (Urologic Sciences); Kishor Wasan (Urologic Sciences) Research Institution: University of British Columbia
March 9, 2023
What is Urology?
Urology is the medical specialty that treats diseases and problems related to the kidneys, ureters, bladder, and urethra. It is also a surgical specialty. Urologists diagnose and treat urinary tract and reproductive system issues in men and women of all ages. They can treat conditions like prostate cancer, erectile dysfunction, urinary tract infections, and more. […]